BAY1082439 T14511
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BAY1082439 is highly effective in inhibiting Pten-null prostate cancer growth[1][2] and it is an orally bioavailable, selective PI3K_/_/_ inhibitor. BAY1082439 also inhibits mutated forms of PIK3CA.
CAS nr:
1375469-38-7
Purity:
98%
Molecular Weight:
494,54
SMILES:
COc1c(OC[C@H](O)CN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cccnc3C)=Nc12
Formula:
C25H30N6O5
Pathway:
PI3K/Akt/mTOR signaling,Apoptosis
Target:
PI3K,Apoptosis
